Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Rolland

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2018
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experienceHéloïse Bourien, Xavier Palard, Yan Rolland, et al.
Cancers|August 7, 2021
ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular CarcinomaCéline Lescure, Florian Estrade, Maud Pedrono, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2015
Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosisEtienne Garin, Yan Rolland, Julien Edeline, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2015
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosisJulien Edeline, Laurence Crouzet, Boris Campillo-Gimenez, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2017
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinomaXavier Palard, Julien Edeline, Yan Rolland, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2018
A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and <sup>90</sup>Y-loaded glass microsphere selective internal radiation therapyVincent Manceau, Xavier Palard, Yan Rolland, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2011
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityYan Rolland, Marc Vérin, Christine A Payan, et al.
JAMA Oncology|November 1, 2019
Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical TrialJulien Edeline, Yann Touchefeu, Boris Guiu, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic CholangiocarcinomasCamille Goislard de Monsabert, Yann Touchefeu, Boris Guiu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 TrialEtienne Garin, Lambros Tselikas, Boris Guiu, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2018
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experienceHéloïse Bourien, Xavier Palard, Yan Rolland, et al.
Cancers|August 7, 2021
ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular CarcinomaCéline Lescure, Florian Estrade, Maud Pedrono, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2015
Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosisEtienne Garin, Yan Rolland, Julien Edeline, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2015
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosisJulien Edeline, Laurence Crouzet, Boris Campillo-Gimenez, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2017
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinomaXavier Palard, Julien Edeline, Yan Rolland, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2018
A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and <sup>90</sup>Y-loaded glass microsphere selective internal radiation therapyVincent Manceau, Xavier Palard, Yan Rolland, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2011
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityYan Rolland, Marc Vérin, Christine A Payan, et al.
JAMA Oncology|November 1, 2019
Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical TrialJulien Edeline, Yann Touchefeu, Boris Guiu, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic CholangiocarcinomasCamille Goislard de Monsabert, Yann Touchefeu, Boris Guiu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 TrialEtienne Garin, Lambros Tselikas, Boris Guiu, et al.
Pageof 7